Table 2.
Multivariate logistic regression for TZ cs-PCa in patients with PSA 4-20 ng/mL.
| Parameters | cs-PCa | |||
|---|---|---|---|---|
| OR | 95% CI | β | P | |
| Age | 1.021 | 0.960-1.086 | 0.021 | 0.500 |
| f/t-PSA | 0.245 | 0.000-190.115 | -1.408 | 0.678 |
| PSAD | 594.440 | 11.395-31010.36 | 6.388 | 0.002∗ |
| PI-RADS v2.1 score | <0.001∗ | |||
| 1 | Ref | |||
| 2 | 0.190 | 0.011-3.205 | -1.663 | 0.249 |
| 3 | 3.312 | 0.382-28.749 | 1.198 | 0.277 |
| 4 | 6.893 | 0.704-67.454 | 1.930 | 0.097 |
| 5 | 35.384 | 3.786-330.724 | 3.566 | 0.002 |
f/t-PSA: free to total PSA ratio; PSAD: prostate-specific antigen density; PI-RADS v2.1: Prostate Imaging Reporting and Data System, version 2.1; cs-PCa: clinically significant prostate cancer; OR: odds ratio; CI: confidence interval. ∗P < 0.05.